Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
Using conceptual work products of case management to design health IT.
Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.
Assessing disability weights based on the responses of 30,660 people from four European countries.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
The brain microvascular endothelium supports T cell proliferation and has potential for alloantigen presentation.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
Evidence for efficacy of a drug widely used without authorisation in multiple sclerosis: mycophenolate mofetil.
Loss of branched o-mannosyl glycans in astrocytes accelerates remyelination.
The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease.
[Detection of anti-aquaporin 4 antibody in neuromyelitis optica].
Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis.
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
Neurological involvement in primary sjögren syndrome: a focus on central nervous system.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
B cells in MS and NMO: pathogenesis and therapy.
Switching therapies in MS: what are the options?
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Longitudinal change detection: Inference on the diffusion tensor along white matter pathways.
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability.
6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Pages
« first
‹ previous
…
511
512
513
514
515
516
517
518
519
…
next ›
last »